早期类风湿关节炎中抗瓜氨酸化蛋白抗体特异性与肺纤维化及其相关基因位点
在1184例早期类风湿关节炎前瞻性起始队列中,841例有ACPA和遗传数据的患者中50例发生影像学定义的肺纤维化,多种ACPA精细特异性及ACPA特异性数量与肺纤维化发生相关。
要点
- 在841例有数据的早期RA患者中,50例发生影像学定义的肺纤维化。
- 多变量分析中6种ACPA特异性与肺纤维化风险增加相关(P<0.01至P<0.05)。
- ACPA特异性数量及部分ACPA特异性在分别校正FAM13A、TOLLIP、MUC5B基因位点后仍与肺纤维化相关。
核心结论
- 在类风湿关节炎起始队列中,肺纤维化的发生与特定ACPA的存在、ACPA特异性数量及风险基因相关。
研究设计与样本
- 前瞻性起始队列研究,连续纳入1184例早期类风湿关节炎患者,自索引日期随访至死亡或2016年12月31日。
- 采用定制微阵列芯片分析21种ACPA精细特异性,并评估3个既往发现与肺纤维化相关的SNP:rs2609255(FAM13A)、rs111521887(TOLLIP)和rs35705950(MUC5B)。
- 841例类风湿关节炎患者有ACPA和遗传数据,其中50例发生影像学定义的肺纤维化。
主要发现
- 在未校正分析中,11种ACPA特异性与肺纤维化发生相关。
- 在多变量分析中,6种ACPA特异性与肺纤维化风险增加相关:波形蛋白(Vim)60-75、纤维蛋白原(Fib)β62-78(72)、Fibα621-635、Bla26、胶原(C)II359-369和F4-CIT-R(P<0.01至P<0.05)。
- ACPA特异性数量也与肺纤维化发生相关(粗模型和校正模型P<0.05)。
- 在分别校正每个SNP的多变量模型中,ACPA特异性数量(所有模型P<0.05)、抗Vim60-75(所有模型P<0.05)、抗Fibβ62-78(72)(P<0.001至P<0.05)、抗CII359-369(所有模型P<0.05)和抗F4-CIT-R AQ4(P<0.01至P<0.05)、抗Fibα621-635(一个模型中P<0.05)和抗Bla26(两个模型中P<0.05)与肺纤维化发生显著相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pulmonary manifestations in RA are common comorbidities, but the underlying mechanisms are largely unknown. The added value of a multiplex of ACPA and genetic risk markers was evaluated for the development of pulmonary fibrosis (PF) in an inception cohort. METHODS: A total of 1184 patients with early RA were consecutively included and followed prospectively from the index date until death or 31 December 2016. The presence of 21 ACPA fine specificities was analysed using a custom-made microarray chip (Thermo Fisher Scientific, Uppsala, Sweden). Three SNPs, previously found related to PF were evaluated, rs2609255 (FAM13A), rs111521887 (TOLLIP) and rs35705950 (MUC5B). ACPA and genetic data were available for 841 RA patients, of whom 50 developed radiologically defined PF. RESULTS: In unadjusted analyses, 11 ACPA specificities were associated with PF development. In multiple variable analyses, six ACPA specificities were associated with increased risk of PF: vimentin (Vim)60-75, fibrinogen (Fib)β62-78 (72), Fibα621-635, Bla26, collagen (C)II359-369 and F4-CIT-R (P < 0.01 to P < 0.05). The number of ACPA specificities was also related to PF development (P < 0.05 crude and adjusted models). In multiple variable models respectively adjusted for each of the SNPs, the number of ACPA specificities (P < 0.05 in all models), anti-Vim60-75 (P < 0.05, in all models), anti-Fibβ62-78 (72) (P < 0.001 to P < 0.05), anti-CII359-369 (P < 0.05 in all models) and anti-F4-CIT-R AQ4 (P < 0.01 to P < 0.05), anti-Fibα621-635 (P < 0.05 in one) and anti-Bla26 (P < 0.05 in two) were significantly associated with PF development. CONCLUSION: The development of PF in an inception cohort of RA patients was associated with both presence of certain ACPA and the number of ACPA specificities and risk genes.
引用
- Brink M, Ljung L, Hansson M, et al. Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis. Rheumatology (Oxford). 2022. PMID: 35532073. doi:10.1093/rheumatology/keac280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。